Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma

Case Reports in Oncological Medicine - Egypt
doi 10.1155/2017/8241624
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Hindawi Limited

Related search

Defining T Cell States Associated With Response to Checkpoint Immunotherapy in Melanoma

Cell
BiochemistryGeneticsMolecular Biology
2019English

Combined Immunotherapy in Metastatic Melanoma With Unknown Primary

Cureus
2019English

Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2007English

Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients With Primary Melanoma

PLoS ONE
Multidisciplinary
2014English

Correlation of Histopathological Patterns in Cutaneous Melanoma With BRAF Mutations

Jornal Brasileiro de Patologia e Medicina Laboratorial
Forensic MedicinePathologyMedical Laboratory TechnologyClinical Biochemistry
2010English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Association of Gender With Efficacy of Immunotherapy in Metastatic Melanoma

Journal of Immunological Sciences
2019English

Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Clinical Cancer Research
Cancer ResearchOncology
2007English

Patterns of Failure After Immunotherapy With Checkpoint Inhibitors Predict Durable Progression-Free Survival After Local Therapy for Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy